Substituted phenyloxazolidinones for antimicrobial therapy

The present invention relates to novel oxazolidinones (Formula I) or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other micr...

Full description

Saved in:
Bibliographic Details
Main Authors Huang, Haihong, Zhang, Doongfeng, Fotouhi, Nader, Cooper, Christopher, Kaneko, Takushi
Format Patent
LanguageEnglish
Published 26.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to novel oxazolidinones (Formula I) or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.
Bibliography:Application Number: NZ20160773022